Targeting PIM kinase activity significantly augments the efficacy of cytarabine

Kevin R. Kelly, Claudia M. Espitia, Pietro Taverna, Gavin Choy, Swaminathan Padmanabhan, Steffan T. Nawrocki, Francis J. Giles, Jennifer S. Carew*

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

19 Scopus citations
Original languageEnglish (US)
Pages (from-to)129-132
Number of pages4
JournalBritish Journal of Haematology
Issue number1
StatePublished - Jan 2012


  • AML
  • Drug resistance
  • Leukaemia therapy
  • New drug development
  • New drugs for leukaemia

ASJC Scopus subject areas

  • Hematology

Cite this